RING - Rituximab for Lupus Nephritis With Remission as a Goal
NCT01673295
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
194
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis
Interventions
DRUG:
RTX infusions
OTHER:
Standard of Care
Sponsor
Frédéric A. Houssiau, MD, PhD